Lykos CEO Resigns

3 months ago

Lykos Therapeutics Inc. Chief Executive Officer Amy Emerson stepped down weeks after US regulators rejected the company’s psychedelic drug MDMA for treatment of post-traumatic stress disorder. Emerson, who has led Lykos since its founding in 2014, will serve as a senior adviser through the end of the year and will serve as an observer on the company’s board, […]